|
Grenzacherstrasse 124 CH-4070 Basel, Switzerland Tel. +41-61-688-11-11 Fax +41-61-691-93-91 |
Type: Public
On the web:
http://www.roche.com
Employees:
78,604
Employee growth: 5.7%
Roche is on a roll. The company operates two segments, pharmaceuticals and diagnostics, and sells its products in more than 150 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan and Herceptin, anemia treatment NeoRecormon/Epogin, hepatitis drug Pegasys, transplant drug CellCept, obesity treatment Xenical, and Tamiflu, which is used to prevent and treat influenza, including avian strains. The company markets many of its bestsellers through subsidiary Genentech and affiliate Chugai Pharmaceutical. Roche's diagnostics arm offers advanced DNA tests, diabetes monitoring supplies, and point-of-care diagnostics used in a variety of health care settings.
Key numbers for fiscal year ending December, 2008:
Sales: $45,355.5M
One year growth: 10.8%
Net income: $10,267.1M
Income growth: 1.1%
Officers:
Chairman: Franz B. Humer
CEO Roche Group: Severin Schwan
CFO and Deputy Head Corporate Executive Committee: Erich Hunziker
Competitors:
Abbott Labs
Merck
Sanofi-Aventis
